CASI Pharmaceuticals
CASI
#10200
Rank
NZ$29.8 M
Marketcap
NZ$1.45
Share price
0.78%
Change (1 day)
-75.46%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.35

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.51. In 2024 the company made an earnings per share (EPS) of NZ-$4.40 a decrease over its 2023 EPS that were of NZ-$3.47.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.35-1.23%
2024NZ-$4.4026.73%
2023NZ-$3.47-32.89%
2022NZ-$5.1811.9%
2021NZ-$4.63-38.44%
2020NZ-$7.51-8.96%
2019NZ-$8.2550%
2018NZ-$5.5077.78%
2017NZ-$3.105.88%
2016NZ-$2.92-22.73%
2015NZ-$3.78-76.09%
2014NZ-$15.82318.18%
2013NZ-$3.78-71.79%
2012NZ-$13.4165.96%
2011NZ-$8.08-50%
2010NZ-$16.16-18.97%
2009NZ-$19.95-63.64%
2008NZ-$54.853.57%
2007NZ-$52.96-60.56%
2006NZ-$134.2997.22%
2005NZ-$68.09-2.7%
2004NZ-$69.98-45.59%
2003NZ-$128.62-61.8%
2002NZ-$336.68-25.52%
2001NZ-$452.06-21.38%
2000NZ-$575.0013.86%
1999NZ-$505.02149.53%
1998NZ-$202.3998.15%
1997NZ-$102.1410.2%
1996NZ-$92.68